[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100586991":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":27,"centralContacts":32,"locations":11,"responsibleParty":38,"collaborators":11,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":45,"acronym":11,"eligibilityCriteria":46,"healthyVolunteers":47,"sex":48,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":11,"studyType":54,"phases":55,"briefSummary":57,"conditions":58,"keywords":11,"overallStatus":60,"whyStopped":11,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":11},{"fullName":5,"class":6},"Cairo University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Neoputty MTA pulpotomy","EXPERIMENTAL",null,[13],"Procedure: NeoPUTTY MTA pulpotomy",{"label":15,"type":10,"description":11,"interventionNames":16},"Endoflas pulpectomy",[17],"Procedure: Endoflas pulpectomy",[19,24],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":11},"PROCEDURE","NeoPUTTY MTA pulpotomy","Neoputty MTA pulpotomy performed in vital primary molars with symptomatic irreversible pulpitis",[9],{"type":20,"name":15,"description":25,"armGroupLabels":26,"otherNames":11},"Endoflas pulpectomy in vital primary molars with symptomatic irreversible pulpitis",[15],[28],{"name":29,"affiliation":30,"role":31},"DR","assistant lecturer","PRINCIPAL_INVESTIGATOR",[33],{"name":34,"role":35,"phone":36,"phoneExt":11,"email":37},"manar motawie el nimr, masters","CONTACT","0201101778899","manar.motawie@dentistry.cu.edu.eg",{"type":31,"investigatorFullName":39,"investigatorTitle":40,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"Manar Motawie Abdulfattah","DR.","100586991","clinical-and-radiographic-success-of-pulpotomy-using-neoputty-mineral-trioxide-aggregate-versus-pulpectomy-using-endoflas-in-primary-molars-with-irreversible-pulpitis-a-randomized-controlled-trial-100586991",false,"NCT06922578","Clinical and Radiographic Success of Pulpotomy Using Neoputty Mineral Trioxide Aggregate Versus Pulpectomy Using Endoflas In Primary Molars With Irreversible Pulpitis: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Children with spontaneous pain lasting a few seconds to several hours.\n* Pain is intensified by thermal stimulus and persists after its removal.\n* Pulp hemorrhage after performing access cavity and deroofing of pulp chamber showing reddish pink healthy pulp tissue.\n* Radicular pulp health is verified by achieving hemostasis within six minutes of compression using a cotton pellet with 2% sodium hypochlorite.\n* Absence of peri-apical or inter-radicular radiolucency, widening of periodontal ligament space, internal or external root resorption.\n\nExclusion Criteria:\n\n* Unrestorable primary molars.\n* Primary molars with uncontrolled pulp hemorrhage or pulp necrosis.\n* Medically compromised patients who have systemic disease.\n* Uncooperative children who refuse treatment.",true,"ALL","4 Years","9 Years",{"count":52,"type":53},66,"ESTIMATED","INTERVENTIONAL",[56],"NA","The goal of this randomized clinical trial is to evaluate the clinical and radiographic success of pulpotomy using Neoputty MTA vital primary molars diagnosed with symptomatic irreversible pulpitis.\n\nThe main question it aims to answer is:\n\nWill Neoputty MTA pulpotomy have higher clinical and radiographic success in comparison to Endoflas pulpectomy in primary molars with irreversible pulpitis?",[59],"Pulpitis - Irreversible","NOT_YET_RECRUITING","2025-04-03",{"date":63,"type":64},"2025-04-10","ACTUAL",{"date":66,"type":53},"2025-05-01",{"date":68,"type":53},"2026-06-01",{"name":5,"class":6}]